Chiltern welcomes Cedric Burg and James Gunter
Chiltern International, a global CRO, has appointed Dr. Cedric Burg and James Gunter to their team.
Burghas been appointed to the position of vice president of global clinical development, Americas. He brings more than 17 years experience in the clinical research field and has a truly international profile having held global senior roles within both a CRO environment and pharma.
Gunter has beenappointed as director of dedicated biometrics services. He brings 16 years in life sciences experience, including 12 years in operational and management roles in the CRO industry. Gunter has spent most of his career leading biometrics and information technology teams globally in the Americas, Europe and Asia. In these roles, he has been responsible for building teams and implementing processes and technologies that improve the efficiency and quality of clinical trials.